(Q33851133)

29 July 2017

1 reference

title

Mutation of cell cycle regulators and their impact on superficial bladder cancer (English)

1 reference

29 July 2017

Rabbani F

1

1 reference

PubMed ID

10696248

29 July 2017

Cordon-Cardo C

series ordinal

2

1 reference

29 July 2017

1 February 2000

1 reference

Urologic Clinics of North America

29 July 2017

1 reference

29 July 2017

27

1 reference

29 July 2017

83-102, ix

1 reference

29 July 2017

1

1 reference

Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

A high prevalence of functional inactivation by methylation modification of p16INK4A/CDKN2/MTS1 gene in primary urothelial cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Expression of mdm-2 and p53 protein in transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Evaluation of epidermal growth factor receptors in bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Frequency of H-ras mutations in human bladder cancer detected by direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Reappraisal of the biological role of epidermal growth factor receptor in transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Frequent and heterogeneous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Mutation Affecting the 12th Amino Acid of the c-Ha- ras Oncogene Product Occurs Infrequently in Human Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

E2F-1 functions in mice to promote apoptosis and suppress proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Immunohistological expression of p53 in primary pT1 transitional cell bladder cancer in relation to tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Mdm2 promotes the rapid degradation of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Oncogenic capacity of the E2F1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Expression of transcription factor E2F1 induces quiescent cells to enter S phase

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Regulation of p53 stability by Mdm2

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

p53 mutations in human bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Correlation between p53 over expression and response to bacillus Calmette-Guerin therapy in a high risk select population of patients with T1G3 bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Screening of human bladder tumors and urine sediments for the presence of H-ras mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Altered patterns of MDM2 and TP53 expression in human bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Oncogenes and bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Original Articles: Bladder Cancer: Long-Term Outcome Related to Epidermal Growth Factor Receptor Status in Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Retinoblastoma gene mutations in primary human bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Interlaboratory variability in fluorescence in situ hybridization analysis. The NCI Bladder Tumor Marker Network.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

A novel cyclin encoded by a bcl1-linked candidate oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The epidermal growth factor receptor and the prognosis of bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Numerical chromosome aberrations in bladder cancer detected by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Immunocytochemical detection of p53 in cultures of exfoliated cells from urine of patients with urothelial cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Amplification of a gene encoding a p53-associated protein in human sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Deletion of the p16 and p15 Genes in Human Bladder Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Long-term efficacy of intravesical bacillus Calmette-Guerin for carcinoma in situ: relationship of progression to histological response and p53 nuclear accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

p53 status does not predict initial clinical response to bacillus Calmette-Guerin intravesical therapy in T1 bladder tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Comparative analysis of MiB1 and p53 expression in human bladder tumors and their correlation with cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Loss of the CDKN2A/p16 locus detected in bladder irrigation specimens by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Does p53 immunostaining improve diagnostic accuracy in urine cytology?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Molecular cytogenetics of bladder cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Y chromosome loss detected by FISH in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Heterogeneity in bladder cancer as detected by conventional chromosome analysis and interphase cytogenetics

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Identification of p53 gene mutations in bladder cancers and urine samples

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Concordance between karyotyping and in situ hybridization procedures in the detection of monosomy 9 in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The voiding pattern in infants with dilating reflux

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Mechanism of activation of a human oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Overexpression of p53 protein and its significance for recurrent progressive bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The prognostic value of p53 in superficially infiltrating transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

p53 mutations have no additional prognostic value over stage in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Comparative analysis of p53 mutations in bladder washings and histologic specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Ras oncogene point mutations in bladder cancer resistant to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Tumor induction and tissue atrophy in mice lacking E2F-1

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Expression of p53 product in Chinese human bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970237-8

7 January 2021

10.1016/S0094-0143(05)70237-8

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10696248